Syringoma - Siringomahttps://en.wikipedia.org/wiki/Syringoma
☆ Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa. Siringoma (Syringoma) enfasizzat minn ċrieki bojod; Dan it-tip ta 'leżjoni l-aktar spiss iseħħ f'nisa fl-40 u l-50 sena. Trattament bil-lejżer (pinhole method) jista 'jkun effettiv fit-titjib tad-dehra tal-leżjoni.
relevance score : -100.0%
References Cutaneous Syringoma: A Clinicopathologic Study of 34 New Cases and Review of the Literature 23919023 NIH
Erbgħa u tletin pazjent kienu maqsuma f'żewġ gruppi (localized and generalized syringoma) . Il-pazjenti kienu l-aktar nisa, li jiffurmaw sebgħa u disgħin fil-mija, b’età medja ta’ 28 sena. Qabel ma fittex kura, il-leżjonijiet kienu ilhom preżenti għal medja ta’ sitt snin. Generalized syringoma affettwa primarjament is-sider u l-għonq, imbagħad id-dirgħajn, filwaqt li localized syringoma instab prinċipalment fuq il-wiċċ, l-axilla, u ż-żona ġenitali.
Thirty-four patients were sorted into two groups, localized and generalized syringoma, according to the Friedman and Butler classification. Ninety-seven percent of the patients were females with the mean age of 27.6 years. The mean duration of the lesions before the presentations was six years. Distribution of the generalized syringoma was mainly in the chest and neck followed by the forearms whereas localized syringoma was mostly confined to the face, axilla and genitalia.
Syringoma: A Clinicopathologic and Immunohistologic Study and Results of Treatment 17326243 NIH
L-istudju tagħna kellu l-għan li jiddeskrivi l-karatteristiċi kliniċi u istopatoloġiċi ta’ wieħed u sittin pazjent iddijanjostikati b’siringoma fuq perjodu ta’ erba’ snin fil-klinika tad-dermatoloġija tagħna fil-Korea. Sibna li s-syringoma affettwa b’mod predominanti lin-nisa, bi proporzjon ta’ 6. 6 nisa għal raġel wieħed, u tipikament dehret matul it-tieni u t-tielet deċennji tal-ħajja f’aktar minn nofs il-pazjenti. Is-sit l-aktar komunement affettwat kien it-tebqet il-għajn (71%) , u l-leżjonijiet kienu fil-biċċa l-kbira tal-kulur tal-ġilda (49%) . Aħna osservajna dehriet karatteristiċi bħal tadpole f'56% tal-każijiet. L-iperpigmentazzjoni bażali kienet aktar komuni f'leżjonijiet ta' kulur kannella, filwaqt li l-fibrożi kienet aktar prevalenti f'leżjonijiet eritematożi. Barra minn hekk, iċ-ċisti tal-keratin kienu inqas komuni f'każijiet li jinvolvu ż-żona ġenitali.
The purpose of our study was to describe clinical and histopathological features of sixty one patients with histological diagnosis of syringoma over four year period in our dermatology clinic in Korea. Female:male ratio was 6.6:1 with onset of age during 2nd and 3rd decades in more than half of the patients in our study. The most frequently involved site was eyelids (43 cases, 70.5%) and the most common color of lesion was skin-color (30 cases, 49.2%). In 34 cases, characteristic tad-pole appearances (55.7%) were observed. Basal hyperpigmentation was observed more frequently in brown-colored lesion (p=0.005). Fibrosis was observed more frequently in erythematous lesion (p=0.033). Keratin cyst was observed less frequently in genital involved group (p=0.006).
Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia 37109186 NIH
[Pinhole technique] - CO2 Trattament bil-lejżer bl-użu tal-metodu pinhole biex jikkura telangiectasias tal-wiċċ huwa trattament sikur, rħas, u effettiv li jipprovdi lill-pazjenti b'sodisfazzjon estetiku eċċellenti.
[Pinhole technique] - CO2 laser treatment using the pinhole method to treat facial telangiectasias is a safe, inexpensive, and effective treatment that provides patients with excellent aesthetic satisfaction.
○ Trattament
#Pinhole technique (Erbium or CO2 laser)